Earnings Feed
Start Free
Home/Filings/4/0001225208-22-003459
4//SEC Filing

Carapezzi William R JR 4

Accession 0001225208-22-003459

CIK 0000078003other
View on SEC.govCompany Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 5:06 PM ET

Size

15.4 KB

Accession

0001225208-22-003459

Insider Transaction Report

Form 4
Period: 2022-02-23
PFIZER INCPFE
Carapezzi William R JR
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2022-02-23$27.34/sh+25,632$700,779→ 82,914 total
  • Tax Payment

    Common Stock

    2022-02-23$46.87/sh−4,057$190,152→ 78,857 total
  • Tax Payment

    Common Stock

    2022-02-23$51.28/sh−12,687$650,589→ 66,170 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2022-02-23−25,632→ 0 total
    Exercise: $27.34From: 2022-02-23Exp: 2022-02-23→ Common Stock (25,632 underlying)
  • Award

    Stock Appreciation Rights

    2022-02-24+22,823→ 22,823 total
    Exercise: $45.96From: 2027-02-24Exp: 2027-02-24→ Common Stock (22,823 underlying)
  • Award

    Stock Appreciation Rights

    2022-02-24+20,073→ 20,073 total
    Exercise: $45.96From: 2029-02-24Exp: 2029-02-24→ Common Stock (20,073 underlying)
Holdings

  • Common Stock

    (indirect: By Rule 16b-3 Plan)
    2,912
Footnotes (6)
  • [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
  • [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
  • [F5]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
  • [F6]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

→
Entity typeother

Related Parties

1
  • filerCIK 0001295078

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:06 PM ET
Size
15.4 KB
View on SEC.gov